{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:22:05Z","timestamp":1769606525425,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ygyno.2015.05.025","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T02:48:26Z","timestamp":1432694906000},"page":"429-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapy"],"prefix":"10.1016","volume":"138","author":[{"given":"Alaattin","family":"Ozen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron D.","family":"Falchook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh A.","family":"Varia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Gehrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.05.025_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0010","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0015","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0020","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicenter randomized trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.05.025_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomized trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.05.025_bb0030","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0035","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0040","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2005.03.007","article-title":"Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review","volume":"63","author":"Scholten","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jama.295.4.389","article-title":"Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma","volume":"295","author":"Lee","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2015.05.025_bb0050","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1471-0528.2007.01332.x","article-title":"Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis","volume":"114","author":"Johnson","year":"2007","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ygyno.2015.05.025_bb0055","first-page":"CD003916","article-title":"Adjuvant radiotherapy for stage I endometrial cancer","volume":"18","author":"Kong","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2004.09.054","article-title":"Intravaginal brachytherapy alone for intermediate-risk endometrial cancer","volume":"62","author":"Alektiar","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomized trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.05.025_bb0070","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0075","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2009.06.027","article-title":"Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation","volume":"116","author":"McCloskey","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0080","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/cncr.11484","article-title":"Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus","volume":"98","author":"Sherman","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.05.025_bb0085","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1200\/JCO.2003.01.218","article-title":"Differences in treatment and outcome between African American and white women with endometrial cancer","volume":"21","author":"Randall","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0090","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000129","article-title":"Influence of comorbidity on the risk of death: a single institution study of 1132 women with early-stage uterine cancer","author":"Elshaikh","year":"2014","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2014.01.032","article-title":"The complex triad of obesity, diabetes and race in type I and II endometrial cancers: prevalence and prognostic significance","volume":"133","author":"Ko","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0105","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/cncr.23717","article-title":"Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?","volume":"113","author":"Maxwell","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.05.025_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0110","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ygyno.2013.05.020","article-title":"Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States","volume":"130","author":"Long","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0115","first-page":"2999","article-title":"Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers","volume":"6","author":"Maxwell","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0120","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/1097-0142(20001015)89:8<1758::AID-CNCR16>3.0.CO;2-A","article-title":"Clinical significance of microsatellite instability in endometrial carcinoma","volume":"89","author":"Basil","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.05.025_bb0125","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0002-9378(96)70036-4","article-title":"p53 overexpression in advanced-stage endometrial adenocarcinoma","volume":"175","author":"Kohler","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0130","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1016\/S0002-9378(97)70380-6","article-title":"Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer","volume":"176","author":"Clifford","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.05.025_bb0135","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ajog.2004.10.605","article-title":"Racial differences in the overexpression of epidermal growth factor type II receptor (HER2\/neu): a major prognostic indicator in uterine serous papillary cancer","volume":"192","author":"Santin","year":"2005","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581530007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581530007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T09:35:40Z","timestamp":1537608940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581530007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S009082581530007X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.05.025","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}